Detalhe da pesquisa
1.
Systemic infusion of TLR3-ligand and IFN-α in patients with breast cancer reprograms local tumor microenvironments for selective CTL influx.
J Immunother Cancer
; 11(11)2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37963636